Imatinib mesylate elicits positive clinical response in atypical chronic myeloid leukemia involving the platelet-derived growth factor receptor beta [5]

  1. Garcia, J.L.
  2. De Mora, J.F.
  3. Hernández, J.M.
  4. Queizan, J.A.
  5. Gutierrez, N.C.
  6. Hernandez, J.M.
  7. San Miguel, J.F.
Revue:
Blood

ISSN: 0006-4971

Année de publication: 2003

Volumen: 102

Número: 7

Pages: 2699-2700

Type: Lettre

DOI: 10.1182/BLOOD-2003-05-1579 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable